Avante! Startup Zavante heads for FDA with revamped antibiotic by Phil Taylor Thursday, April 6, 2017 With phase 3 data in hand, Zavante is hoping to file its repurposed antibiotic Zolyd for complicated urinary tract infections in the U.S. early next year.
